tiprankstipranks
China Resources Pharmaceutical Group Ltd. (HK:3320)
:3320
Hong Kong Market
3320
China Resources Pharmaceutical Group Ltd.
RESEARCH TOOLSreports
Want to see HK:3320 full AI Analyst Report?

China Resources Pharmaceutical Group Ltd. (3320) Stock News & Sentiment

4 Followers
China Resources Pharma Discloses Subsidiary’s Unaudited Q1 2026 Results Linked to PRC Note Issuance
Premium
Company Announcements
China Resources Pharma Discloses Subsidiary’s Unaudited Q1 2026 Results Linked to PRC Note Issuance
9d ago
China Resources Pharmaceutical Completes RMB1.4 Billion Second Tranche of 2026 Bonds in China
Premium
Company Announcements
China Resources Pharmaceutical Completes RMB1.4 Billion Second Tranche of 2026 Bonds in China
12d ago
China Resources Pharmaceutical Discloses Weaker Q1 2026 Unaudited Results at Boya Bio-Pharmaceutical
Premium
Company Announcements
China Resources Pharmaceutical Discloses Weaker Q1 2026 Unaudited Results at Boya Bio-Pharmaceutical
15d ago
CR Pharmaceutical Subsidiary CR Sanjiu Posts Higher Q1 Revenue but Weaker Cash Flow
Premium
Company Announcements
CR Pharmaceutical Subsidiary CR Sanjiu Posts Higher Q1 Revenue but Weaker Cash Flow
16d ago
China Resources Pharma Flagship KPC Swings to Q1 Loss on Slumping Revenue
Premium
Company Announcements
China Resources Pharma Flagship KPC Swings to Q1 Loss on Slumping Revenue
16d ago
CR Double-Crane Posts Softer Q1 Earnings but Stronger Cash Position for 2026
Premium
Company Announcements
CR Double-Crane Posts Softer Q1 Earnings but Stronger Cash Position for 2026
16d ago
CR Jiangzhong Q1 2026 Profit Rises on Strong Cash Flow Despite Revenue Dip
Premium
Company Announcements
CR Jiangzhong Q1 2026 Profit Rises on Strong Cash Flow Despite Revenue Dip
16d ago
More HK:3320 News >

3320 News on the Web

China Resources Pharmaceutical Raises RMB1.5 Billion in First Tranche of 2026 Bonds
TipRanks News
Bullish
China Merchants Securities Sticks to Its Buy Rating for China Resources Pharmaceutical Group Ltd. (640)
TipRanks News
Bullish
China Resources Pharmaceutical Group Ltd. (640) Receives a Buy from CICC
TipRanks News
Bullish
UBS Keeps Their Buy Rating on China Resources Pharmaceutical Group Ltd. (640)
TipRanks News
Bullish
Nomura Remains a Buy on China Resources Pharmaceutical Group Ltd. (640)
TipRanks News
Bullish
Bank of America Securities Remains a Buy on China Resources Pharmaceutical Group Ltd. (640)
TipRanks News
Bullish
China Resources Pharma Unit to Invest RMB1.5 Billion in New Health Consumer Products Park
TipRanks News
Neutral
China Resources Pharma Launches RMB1.42 Billion Tender to Sell Tianmai Biotechnology Stake
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
HK:3320
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.25 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:3320’s Media Buzz Sentiment?
1 articles about HK:3320 were published this week. In an average week, 1.25 articles are published.
    What is HK:3320’s weekly average amount of articles?
    In an average week, 1.25 articles about HK:3320 are published.
      What is HK:3320’s News Sentiment?
      100% of articles about HK:3320 were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week